Navigation Links
CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- At today's National Prescription Drug Abuse Prevention Policy Consensus Meeting, the not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) announced the results of its national contest to identify the "Top 5 Technologies To Reduce Prescription Drug Abuse." 

In alphabetical order, the Top 5 honorees are …

  • Atlantic Pharmaceuticals' SMART/Script dosage form to decrease medication tampering;
  • Eagle Advancement Institute's Clarity program for opioid detoxification, addiction treatment, and aftercare;
  • Egalet's erosion-based drug delivery platform, designed to resist tampering;
  • The Locking Cap, a combination bottle cap to prevent unauthorized access to prescription medications, particularly by children and teens; and
  • Pisgah Labs' P2P Interventions process, designed to safeguard medications' active ingredients.

Honorable mention goes to Abuse Tech's Abuse-Loc, a locking medication bottle to prevent the diversion of drugs from homes.

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "These companies have demonstrated a sincere commitment to reducing prescription drug abuse. We hope the Top 5 Technologies recognition will expedite their success in meeting that goal."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize the Top 5 honorees joining Millennium in the critically important effort to advance patient care and help address the epidemic of prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is the sponsor of the National Prescription Drug Abuse Prevention Policy Consensus meeting.  In its fifth year, the annual event brings together representatives of government, non-profit health and safety organizations, and industry to identify how best to reduce prescription drug abuse while optimizing patient care.  Follow @claad_coalition.

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
4. Isis Reports Financial Results and Highlights for First Quarter 2012
5. Delcath Highlights First Quarter 2012 And Recent Accomplishments
6. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
7. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
8. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
9. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
10. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
11. Cardinal Health Highlights Independent Pharmacy Best Practices At Retail Business Conference 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):